Guang Liang

19PUBLICATIONS
21CO-AUTHORS
Molecular targetsBiomolecular modelling and designCardiology (incl. cardiovascular diseases)Biologically active moleculesComputational physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 31, 2026
Discovery of a covalent FGFR2-selective inhibitor overcoming clinically-acquired resistance mutations.

|Jul 12, 2026
Cardiomyocyte-enriched OTUD5 alleviates septic cardiomyopathy by promoting NLRP3 deubiquitination and inhibiting NLRP3 inflammasome activation.

|Jun 12, 2026
Design, Synthesis, and Biological Evaluation of a MyD88-Targeted Molecular Glue d21 for the Treatment of Acute Lung Injury.

|May 17, 2026
VCPIP1 drives diabetic cardiomyopathy by deubiquitinating AMPKγ1 and preventing AMPKα-γ subunit assembly in cardiomyocytes.

|May 10, 2026
The E3 Ubiquitin Ligase RNF123 Mediates Pathological Cardiac Hypertrophy by Ubiquitinating PRDX1 and Upregulating Oxidative Stress in Cardiomyocytes.

|May 01, 2026
Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF-κB-mediated inflammation and alleviate atherosclerosis.

Pageof 4

Frequent Collaborators

4 joint publications

Bozhi Ye

2 joint publications

Zhiwei Zheng

2 joint publications

Lingfeng Chen

2 joint publications

Zheng Xu